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1. Introduction 
Treatment of human disorders by the direct admin- 
istration of drugs can be hampered by immunological 
reactions, development of drug resistance, uptake of 
drugs by non-diseased tissues often leading to serious 
side effects, or even by the inability of some drugs to 
penetrate target cells. A general carrier within which 
drugs could be entrapped and directed to target tis- 
sues might help to eliminate some of these problems 
and it has been suggested that the need for such a car- 
rier could be satisfied by liposomes [ 1,2] . Liposomes 
are spherules formed when phospholipids are allowed 
to swell in aqueous media and they consist of concen- 
tric lipid bilayers alternating with aqueous compart- 
ments. Within the aqueous or lipid phase of liposomes, 
water or lipid-soluble substances respectively can be 
entrapped [3] . Work with enzyme-containing lipo; 
somes injected into rats has shown that liposomes can 
carry enzymes into the liver and spleen [ 1,4,5] . 
In this report the possibility of employing lipo- 
somes as drug carriers is examined. The choice of 
drugs for entrapment studies included actinomycin D 
because of its deleterious effect on non-diseased rapid- 
ly dividing cells (i.e. intestinal wall) in cancer chemo- 
therapy [6] and penicillin because of its failure to 
penetrate cells of the reticuloendothelial system (i.e. 
spleen) in antimicrobial therapy [6]. Experiments 
with liposomes-entrapped and non-entrapped drugs in- 
jected into rats revealed that entrapment directed to a 
considerable extent the rate of drug elimination from 
the plasma and drug tissue distribution. 
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2. Materials and methods 
The sources and grades of egg lecithin, cholesterol 
and phosphatidic acid have been described elsewhere 
[ 1,4, S] . Synthetic fl-y-dipalmitoyl D, L-o-glyceryl 
phosphoryl choline (dipalmitoyl lecithin), grade I was 
purchased from Sigma (London) U.K., and stearyl- 
amine (octadecylamine) from K and K Inc., N.Y., 
U.S.A. Potassium benzyl penicillin was from Dista 
Products Ltd., Liverpool, U.K., and actinomycin D 
from Merck, Sharp and Dohme, Pa., U.S.A. Potassium 
[14Clbenzyl penicillin (potassium 6-phenyl [acet-l- 
14C] amido-penicillanate, 38.2 mCi/mmol), and 
[3H]actinomycin D (3.7 Ci/mmol) were from The 
Radiochemical Centre, Amersham, U.K. and 1251- 
labelled human serum albumin (1 pCi/mg) was kindly 
donated by Dr. G. Smith of this Centre. For entrap- 
ment [ 1,4,5] of drugs mixed with their labelled de- 
rivatives in liposomes, lipids (see table 1) were dis- 
solved in CHCl, and after evaporation under reduced 
pressure the lipid layer on the walls of the flask was 
dispersed (at 60-70°C when dipalmitoyl lecithin was 
present) with 2 ml water containing the drugs (see 
table 1). Actinomycin D was also entrapped in the lip- 
id phase of liposomes by dissolving the drug and lipids 
in CHCl, and dispersing the lipid layer after evapora- 
tion of the solvent with 1% NaCl. Four to six hours 
after their sonication [5] , liposomal suspensions were 
passed through a Sepharose 6B column (Pharmacia) 
to separate drug-containing liposomes from the non- 
entrapped drug. In some experiments [125~]albumin 
was entrapped in liposomes composed of dipalmitoyl 
lecithin, cholesterol and phosphatidic acid or egg lec- 
ithin, cholesterol and stearylamine [l] . Entrapment 
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Table 1 
Drug entrapment in liposomes. 
Lipids 
% Entrapped* 
Penicillin Actinomycin D 
DPL, CHOL, STEAR 5.4 11.0 
6.0 11.6 
4.5 
EL, CHOL, STEAR 5.6 8.8 
7.2 8.5t 
9.2t 
DPL, CHOL, PA 8.4 7.0 
3.9 6.8 
7.5 
EL, CHOL, PA 3.2 2.3 
2.2 3.3 
2.3 t 
Et 
Potassium [ 14C]benzyl penicillin (10 mg and 5-29 r.rCi) and 
[3H]actinomycin D (0.05-0.10 mg and 15 r&i) were en- 
trapped in liposomes composed of 15 mg dipalmitoyl lecithin 
(DPL) or egg lecithin (EL) each supplemented with 2.2 mg 
cholesterol (CHOL) and 0.81 mg stearylamine (STEAR) or 
2.12 mg phosphatidic acid (PA) (see the Materials and methods 
section). The molar ratio for each set of phospholipid, choles- 
terol and charged lipid was 7: 2: 1. 
Entrapment of drugs in liposomes prepared in the absence of 
charged lipids was negligible. 
* % of the radioactivity of the drug used associated with lipo- 
somes following molecular sieve chromatography. 
t Drug entrapped in the lipid phase of liposomes. 
of albumin in stearylamine liposomes was carried out 
in 0.1 M acetate buffer pH 4.5. 
Male rats (Wistar) weighing lOO- 150 g were in- 
jected in their tail vein with 1 ml of appropriate solu- 
tions of labelled non-entrapped drugs in 1% NaCl or 
with labelled drugs or albumin previously entrapped in 
liposomes, and decapitated at time intervals. Radioac- 
tivity was measured [5] in the plasma and the homog- 
enates [5] of several tissues. 
3. Results and discussion 
Liposomes were prepared using a phospholipid (di- 
palmitoyl or egg lecithin), cholesterol and either 
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Fig. 1. Elimination from the blood of non-entrapped and 
liposome-entrapped potassium [ 14C] benzyl penicillin. Rats 
were injected with 28 pg (9 X 10’ dpm) non-entrapped potas- 
sium benzyl penicillin (o-o-o) 30 c(g (8.2 X 10’ dpm) lipo- 
some-entrapped potassium benzyl penicillin (e-e-e) or 
0.31 mg (7.2 x lo4 cpm) liposome-entrapped [ ‘*‘I]albumin 
(A-A-A). Liposomes (2.5 mg lipid) were composed of di- 
palmitoyl lecithin, cholesterol and phosphatidic acid (see leg- 
end to table 1). Owing to slow loss of entrapped drugs 
through diffusion on standing, liposomes were used within 
hours following their preparation. No such loss was observed 
with liposomes containing actinomycin D in their lipid phase 
45 days after entrapment. At time intervals radioactivity was 
measured in the plasma the volume of which was taken as 9.8 
ml/l00 g body weight [ 51. Each point % of the radioactivity 
injected is the average value from 2 to 3 rats. 
stearylamine (positive liposomes) or phosphatidic acid 
(negative liposomes) in a molar ratio of 7: 2: 1 [ 1 ] . Di- 
palmitoyl lecithin was used because the absence of 
double bonds in its paraffin chains enhances solute en- 
trapment [7] which is also enhanced by cholesterol 
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F&. 2. Time course of uptake and persistence of potassium 
[ C] benzyl penicillin in rat tissues. Rats were injected with 
non-entrapped or liposome-entrapped potassium benzyl peni- 
cillin as described in fig. 1. At time intervals radioactivity was 
measured in the tissue homogenates and, when appropriate, 
corrected for blood contamination. The height of each bar 
(% of the injected radioactivity per whole tissue) is the aver- 
age value from 2 to 3 rats. Hatched bars: non-entrapped 
drugs; filled bars: liposome-entrapped drugs. 
[8] . Charged lipids were used because mey increase 
the volume of aqueous spaces within the liposomes, 
hence the amount of entrapped solutes [9], and they 
delay diffusion of entrapped ions of homologous 
charge [lo] . It is apparent from table 1 that values 
for penicillin and actinomycin D entrapment (% of 
the drug used) in liposomes containing dipalmitoyl 
lecithin or stearylamine in their structure are, for 
each drug, higher than those observed with egg leci- 
thin-phosphatidic acid liposomes. This could be attri- 
buted to the superiority of dipalmitoyl lecithin over 
egg lecithin in enhancing solute entrapment [7] and, 
for at least the weakly basic actinomycin D, to an 
homologous charge effect [lo] . 
In preliminary experiments non-entrapped drugs 
and drugs or [ 1 251] albumin entrapped in liposomes 
of lipid composition shown in table 1 were injected 
into rats. It was found that 5 min after injection plas- 
ma concentration values (% of the injected dose) of 
entrapped drugs, depending on the lipid composition 
of the carrier, varied between those for the correspond- 
ing non-entrapped drugs (l-7%) and those for lipo- 
some-entrapped albumin (60-70% of the dose). Peni- 
cillin- or actinomycin D-containing liposomal prepara- 
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Fig. 3. Elimination from blood of non-entrapped and lipo- 
some-entrapped [3H]actinomycin D. Rats were injected with 
1.5 pg (2.1 X lo6 dpm) non-entrapped actinomycin D 
(o-o-o), 1.2 clg (5.5 X 10’ dpm) actinomycin D en- 
trapped in the lipid phase of liposomes (e-e-e) or 0.21 
mg (8.5 X lo4 cpm) liposome-entrapped [‘2SI]albumin 
(A-A-A). Liposomes (2.5 mg lipid) were composed of egg 
lecithin, cholesterol and stearylamine (see legend to table 1). 
Each point is the average value from 2 to 3 rats. 
tions that exhibited drug plasma values approaching 
those for entrapped albumin (figs. 1 and 3) as well as 
non-entrapped drugs were injected into rats and their 
fate investigated. 
Soon after injection of non-entrapped [ 14C:3 peni- 
cillin most radioactivity was removed from the circula- 
tion (fig. 1) and some of it transiently recovered in the 
liver (22.7%), kidney (9.5%) and spleen (1% of the 
dose) (fig. 2). In contrast, not only entrapped 
[14C]peniciIlin exhibited a slower rate of plasma dis- 
appearance (fig. 1) but half the radioactivity injected 
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Fig. 4. Time course of uptake and persistence of [ 3H]actino- 
mycin D in rat tissues. Rats were injected with non-entrapped 
and liposome-entrapped actinomycin D as described in fig 3. 
Maximum uptake of radioactivity by the spleen was 1.2% and 
4.7% for the non-entrapped and the entrapped drug respec- 
tively. Other details are given in the legend of fig. 2. 
was found in the liver (42%) and spleen (8% 20 mm) 
and a considerable amount of it was still retained by 
these tissues 2.5 hr later (fig. 2). Injection of non-en- 
trapped [3H]actinomycin D also resulted in its rapid 
removal from the plasma (fig. 3). Radioactivity was 
partially recovered in the small intestine, liver and kid- 
ney (fig. 4) and although 2.5 hr later very little of it 
was left in the liver and kidney considerable amounts 
were held by the small intestine (18% of the dose). En- 
trapment of [3H]actinomycin D in the lipid phase of 
liposomes led to a dramatic change in its rate of plas- 
ma removal to levels similar to those for entrapped al- 
bumin and 2.5 hr after injection 38% of the dose was 
still present in the circulation (fig. 3). Further, there 
was now little radioactivity uptake by the small intes- 
tine (5% at most) and kidney, there was more radioac- 
tivity in the spleen, and radioactivity uptake by the liv- 
er increased with time (23% of the dose in 2.5 hr, fig. 
4 and legend). 
Despite the rapid loss from the circulation of en- 
trapped penicillin (presumably following its diffusion 
through the liposomal membranes) (fig. 1) it is ap- 
parent from tissue uptake values (fig. 2) that, as with 
actinomycin D entrapped in the lipid phase of lipo- 
somes, a considerable portion of this drug was directed 
by the carrier into the liver and spleen. However, as 
no attempt was made to identify tissue radioactivity, 
it is not known to what extent measured labels repre- 
sent the original drugs. 
Earlier work has shown that liposomes can trans- 
port enzymes in a latent state into the rat liver lyso- 
somes [l] and the lysosomes of cultured macro- 
phages and fibroblasts [ 1 l] . Once in lysosomes en- 
zymes regain their activity towards substrates stored 
in lysosomes [ 1 I] presumbaly following the rupture 
of liposomal membranes by lysosomal lipases or other- 
wise. It is conceivable that in the present experiments 
administration of liposome-entrapped rugs has also 
led to a similar lysosomal localization of liposome- 
entrapped drugs in the liver and spleen. After disrup- 
tion of the carrier’s membranes drugs can then act 
either within the lysosomes or, following diffusion, 
in other cellular compartments (i.e. nucleus). Cou- 
pling of drugs to DNA [ 121 or other molecules [ 131 
through bonds vulnerable to lysosomal enzymes has 
also been proposed as a possibility for chemotherapy 
through lysosomes [ 141. The use of liposomes as 
drug(s) carriers requires disruption of the lipid bilayers 
by a lysosomal action which is common to the libera- 
tion of any entrapped drug. Owing to the chemical 
composition of liposomes and the insulation of the 
entrapped drugs from the environment (when diffu- 
sion is minimal) immunological reaction and develop- 
ment of drug resistance, due in some cases to changes 
in cell membrane permeability to drugs [ 151, might 
not occur. Further, it might be possible to direct lipo- 
somes to cells other than those of the liver and spleen 
through specific manipulations of the liposomal sur- 
face [ 1,161 . Comparative studies on the biological ef- 
fect of liposome-entrapped and non-entrapped drugs are 
now in progress. 
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